0001193125-10-107257 Sample Contracts

MYRIAD GENETICS, INC. Form of Executive Retention Agreement

Retention Agreement • May 5th, 2010 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah

• Contract Type
  Retention Agreement
• Filed
  May 5th, 2010
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Utah

THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and (the “Executive”), is made as of February 17, 2005 (the “Effective Date”).

AMENDMENT TO LEASE AGREEMENT (Myriad Genetics: Phase v)

Lease Agreement • May 5th, 2010 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances

• Contract Type
  Lease Agreement
• Filed
  May 5th, 2010
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances

THIS AMENDMENT TO LEASE AGREEMENT (the “Amendment”) is entered into the 12th day of February 2010, by and between BOYER RESEARCH PARK ASSOCIATES IX, L.C., a Utah limited liability company (“Landlord”), and MYRIAD GENETICS, INC., a Delaware corporation (“Tenant”).

MYRIAD GENETICS, INC. Amendment to Executive Retention Agreement

Executive Retention Agreement • May 5th, 2010 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah

• Contract Type
  Executive Retention Agreement
• Filed
  May 5th, 2010
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Utah

THIS AMENDMENT TO EXECUTIVE RETENTION AGREEMENT (the “Amendment”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and (the “Executive”), is entered into effective as of October 12, 2007 (the “Effective Date”).